Harrington Investments’s Pfizer PFE Stock Holding History

Harrington Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,922	Closed	-$206K	–	77
2022 Q2	$206K	Hold	3,922	–	–	0.15%	76
2022 Q1	$203K	Buy	3,922 +187	+5%	+$9.7K	0.12%	79
2021 Q4	$221K	Buy	+3,735	New	+$185K	0.12%	82
2018 Q4	–	Sell	-4,724	Closed	-$198K	–	121
2018 Q3	$198K	Buy	4,724 +6	+0.1%	+$231	0.16%	81
2018 Q2	$162K	Sell	4,718 -830	-15%	-$28.4K	0.14%	86
2018 Q1	$187K	Sell	5,548 -836	-13%	-$28.7K	0.15%	82
2017 Q4	$219K	Buy	+6,384	New	+$218K	0.18%	82

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harrington Investments's PFE Position: Q3 2022 in Review

Harrington Investments sold out of Pfizer (PFE) in Q3 2022, closing a stake of 3,922 shares — an estimated $206K sold.

Harrington Investments first reported a position in PFE in Q4 2017 and held it in 7 quarters. The position peaked at $221K in Q4 2021. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

Harrington Investments reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
Harrington Investments sold 3,922 Pfizer shares in Q3 2022, an estimated $206K.
Harrington Investments first reported a position in Pfizer in Q4 2017 and held it in 7 quarters.
Harrington Investments's Pfizer position peaked at $221K in Q4 2021.
3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Harrington Investments's 13F filing for Q3 2022, filed 19 Oct 2022.